Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients

BACKGROUND: The efficacy of switching to tenofovir disoproxil fumarate (TDF) monotherapy from lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy (stable switching) in patients with LAM-resistant chronic hepatitis B (CHB) and undetectable hepatitis B virus (HBV) DNA is not clear. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Heon Ju, Kim, Sang Jin, Kweon, Young Oh, Park, Soo Young, Heo, Jeong, Woo, Hyun Young, Hwang, Jae Seok, Chung, Woo Jin, Lee, Chang Hyeong, Kim, Byung Seok, Suh, Jeong Ill, Tak, Won Young, Jang, Byoung Kuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766122/
https://www.ncbi.nlm.nih.gov/pubmed/29329305
http://dx.doi.org/10.1371/journal.pone.0190581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766122/
https://www.ncbi.nlm.nih.gov/pubmed/29329305
http://dx.doi.org/10.1371/journal.pone.0190581

Ejemplares similares